Medica RCP |Merozan | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Merozan

To avoid
As a precautionary measure

Contraindicated

Merozan :
Type	Medicine Authorised
Originator	Meronem 1g
Agent	Macromed
Distributor	Macromed
Laboratory	Demo
Responsible Party	Demo SA
Origin	Greece
Manufacturer	Demo SA
Manufacturing Type	G
Origin	Greece
ATC	J01DH02

Merozan :

Injectable

Intravenous

Merozan :

J Anti-Infectives for systemic use

J01 Antibacterials for systemic use

J01D Other betalactams

J01DH Carbapenems

J01DH02 Meropenem

Merozan :

Meropenem : 1g

Merozan :

Adults : Febrile neutropenia 1 g, 3 times daily

Adults : Intra-abdominal Infections 500 -1000mg, 3 times per day

Adults : Intra-partum infections 500 -1000mg, 3 times per day

Adults : Meningitis 2 g TID

Adults : Pneumonia 500 -1000mg

Adults : Post-partum infections 500 -1000mg, 3 times per day

Adults : Pulmonary infections 2 g TID

Adults : Skin and soft tissue infections 500 -1000mg, 3 times per day

Adults : Urinary tract infection 500 -1000mg, 3 times per day

Merozan :

Revision Date : 01/02/2016

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal pain	Common
Agranulocytosis	Uncommon
Anaphylaxis	Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema)	Uncommon
Antibiotic associated colitis	Uncommon
Blood bilirubin increased	Uncommon
Blood lactate dehydrogenase increased	Common
Blood urea increased	Uncommon
Cephalea	Common
Convulsion	Rare
Creatinine increased	Uncommon
Diarrhoea (Diarrhea)	Common
Eosinophilia	Uncommon
Erythema multiforme	Uncommon
Haemolytic anemia	Uncommon
Inflammation (Inflammatory reaction)	Common
Injection site pain	Uncommon
Leucopenia (Leukopenia)	Uncommon
Lyell Syndrome (Toxic epidermal necrolysis)	Uncommon
Nausea	Common
Neutropenia	Uncommon
Oral candidiasis	Uncommon
Pain	Common
Phosphatase alkaline increased	Common
Pruritus	Common
Skin Eruption	Common
Stevens-Johnson syndrome	Uncommon
Thrombocythaemia	Common
Thrombocytopenia (Thrombopenia)	Uncommon
Thrombophlebitis	Uncommon
Transaminases increased	Common
Urticaria	Uncommon
Vaginal candidiasis	Uncommon
Vomiting	Common

Merozan :

Cyprus

Greece

Lebanon

Form	Powder for solution for injection
Packaging	Bottle
Package Size	Box of 10
Strength	N/A
Public Price	7634958.18 L.L.
Stratum	C
NSSF	✘
Quarantine	✘
Reg. Number	112620/1
Submission date	2020
Registration Year	06/11/2023

● Country:	Lebanon
● Form:	Powder for solution for injection
● Package Size:	Box of 10
● Public Price:	7634958.18 LBP	( 7,634,958.18 LBP )
● Pack size unit used:	10
● Cost/Unit:	763495,82 LBP	( 763,495.00 LBP )
● Pricing Date:	13/06/2024

P.P. =	Public Price
P/U =	Price Per Unit

Medicine Authorised

Archifar 1g

P.P. : 14168341.61 LBP

( Box of 10 )

P/U: 1416834.16 LBP

New AllPharma

Medochemie

Medicine Authorised

Aropem 1g

P.P. : 1695033.34 LBP

( Box of 1 )

P/U: 1695033.34 LBP

Raymond Georges Abou Adal

Arwan Laboratories

Medicine Authorised

Aropem 1g²

P.P. : 1695033.34 LBP

( Box of 1 )

P/U: 1695033.34 LBP

Raymond Georges Abou Adal

Arwan Laboratories

Medicine Authorised

Aropem 1g³

P.P. : 1695033.34 LBP

( Box of 1 )

P/U: 1695033.34 LBP

Raymond Georges Abou Adal

ACS Dobfar

Medicine Authorised

Aropem 1g⁴

P.P. : 29098108.26 LBP

( Box of 1 )

P/U: 29098108.26 LBP

Raymond Georges Abou Adal

Arwan Laboratories

Medicine Authorised

Merocare

P.P. : 1327716.39 LBP

( Box of 1 )

P/U: 1327716.39 LBP

Drugstore 3U

Swiss Exports

Medicine Authorised

Merolin 1g IV

P.P. : 5133154.81 LBP

( Box of 3 )

P/U: 1711051.6 LBP

Drugstore 3U

Facta Farmaceutici s.p.a

Medicine Authorised

Meronem 1g

P.P. : 26272721.56 LBP

( 10x30ml )

P/U: 2627272.16 LBP

Droguerie Fattal

Pfizer

Medicine Authorised

Meropenem Anfarm

P.P. : 7624551.02 LBP

( Box of 10 )

P/U: 762455.1 LBP

Medi Drug International

Anfarm Pharmaceuticals

Medicine Authorised

Meropenem Labatec 1g

P.P. : 12764390.82 LBP

( Box of 10 )

P/U: 1276439.08 LBP

Levant Alie Houses

Labatec Pharma

Medicine Authorised

Meropenem Panpharma

P.P. : 16843940.67 LBP

( Box of 10 )

P/U: 1684394.07 LBP

Minapharm Halabi

Panpharma

Medicine Authorised

Merozan

P.P. : 907093.69 LBP